MPWT
MRTX

MassMutual Private Wealth & Trust’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4
Closed -$1K – 1671
2021
Q4 		$1K Buy
+4
New +$621 ﹤0.01% 1354

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

MassMutual Private Wealth & Trust's MRTX Position: Q1 2022 in Review

MassMutual Private Wealth & Trust sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2022, closing a stake of 4 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in MRTX in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 253 funds tracked by Wall St. Rank hold MRTX as of Q1 2022.

  • MassMutual Private Wealth & Trust reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 4 Mirati Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Mirati Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2021.
  • 253 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2022, filed 8 Apr 2022.